Drug-induced liver injury: Expanding our knowledge by enlarging population analysis with prospective and scoring causality assessment

Gastroenterology

Volumn 148, Issue 7, 2015, Pages 1271-1273

  Teschke, Rolf ^a   Andrade, Raúl J ^b,c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina IBIMA Plataforma Bionand   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL;

ADVERSE OUTCOME; CLINICAL ASSESSMENT; COMORBIDITY; EDITORIAL; HUMAN; INCIDENCE; LIVER FAILURE; LIVER TOXICITY; PRIORITY JOURNAL; TOXIC HEPATITIS; DRUG-INDUCED LIVER INJURY; FEMALE; INTEGRATED HEALTH CARE SYSTEM; LIVER FAILURE, ACUTE; MALE; STATISTICS AND NUMERICAL DATA;

DELIVERY OF HEALTH CARE, INTEGRATED; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; LIVER FAILURE, ACUTE; MALE;

EID: 84930016056     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.04.027     Document Type: Editorial

References (20)

1. R.J. Andrade, M.I. Lucena, and M.C. Fernández Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period Gastroenterology 129 2005 512 521
2. N. Chalasani, R.J. Fontana, and H.L. Bonkovsky Drug-Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States Gastroenterology 35 2008 1924 1934
3. N. Chalasani, H.L. Bonkovsky, and R. Fontana Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study Gastroenterology 148 2015 1340 1352
4. D.S. Goldberg, K.A. Forde, and D.M. Carbonari Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system Gastroenterology 148 2015 1353 1361
5. E.S. Björnsson, O.M. Bergmann, and H.K. Björnsson Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland Gastroenterology 144 2013 1419 1425
6. L.B. Seeff, H.L. Bonkovsky, and V.J. Navarro Herbal products and the liver: 1 review of adverse effects and mechanisms Gastroenterology 148 3 2015 517 532.e3
7. R. Teschke, A. Wolff, and C. Frenzel Review article: herbal hepatotoxicity - an update on Traditional Chinese Medicine preparations Aliment Pharmacol Ther 40 2014 32 50
8. G.P. Aithal, P.B. Watkins, and R.J. Andrade Case definition and phenotype standardization in drug-induced liver injury Clin Pharmacol Ther 89 2011 806 815
9. M.I. Lucena, R.J. Andrade, and N. Kaplowitz Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex Hepatology 49 2009 2001 2009
10. M.I. Lucena, R.J. Andrade, and M.C. Fernandez Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain Hepatology 44 2006 850 856
11. K. Jinjuvadia, W. Kwan, and R.J. Fontana Searching for a needle in the haystack: use of ICD-9-CM codes in drug-induced liver injury Am J Gastroenterol 102 2007 2437 2443
12. C. Bénichou, G. Danan, and A. Flahault Causality assessment of adverse reactions to drugs - II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge J Clin Epidemiol 46 1993 1331 1336
13. R. Teschke, A. Wolff, and C. Frenzel Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment World J Hepatol 6 2014 17 32
14. R. Teschke, and A. Eickhoff Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps Front Pharmacol 2015 in press
15. M. García-Cortés, C. Stephens, and M.I. Lucena Causality assessment methods in drug induced liver injury: Strengths and weaknesses J Hepatol 55 2011 683 691
16. J. Rochon, P. Protiva, and L.B. Seeff Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury Hepatology 48 2008 1175 1183
17. V.K. Agarwal, J.G. McHutchison, and J.H. Hoofnagle Drug-Induced Liver Injury Network (DILIN). Important elements for the diagnosis of drug-induced liver injury Clin Gastroenterol Hepatol 8 2010 463 470
18. R. Teschke Black cohosh and suspected hepatotoxicity - inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm: a critical review Menopause 17 2010 426 440
19. T.J. Davern, N. Chalasani, and R.J. Fontana Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury Gastroenterology 141 2011 1665 1672
20. R. Teschke, C. Frenzel, and A. Wolff Drug induced liver injury: accuracy of diagnosis in published reports Ann Hepatol 13 2014 248 255